Skip to content

Diagnosis of pre-eclampsia.

Diagnosis of pre-eclampsia.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON20514
Enrollment
20
Registered
2010-09-20
Start date
2010-11-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pre-eclampsia

Interventions

None listed

Sponsors

Laboratory for Clinical Chemistry & Haematology Atrium Medisch Centrum Parkstad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Case: Pregant women with suspected pre-eclampsia. Control: Pregnant women admitted for a primary C. section.

Exclusion criteria

Exclusion criteria: Case: 1. Pre-existing hypertension. Control: 1. Presence of contractions; 2. Pre-existing hypertension.

Design outcomes

Primary

MeasureTime frame
Difference between pregnant women with and without pre-eclampsia for the biomarkers sFlt-1, PlGf and ratio.

Secondary

MeasureTime frame
1. Is the value of sFlt-1, PlGf and ratio a prognostic measure to assess severity of the disease? 2. Can these markers be used to make a desiscion on management of the pregnant women (estrictive vs. proactive).

Contacts

Public ContactM.T.M. Raijmakers

PO Box 4446

mraijmakers@atriummc.nl+31 (0)45 5766340

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)